Cargando…
KDM4 Involvement in Breast Cancer and Possible Therapeutic Approaches
Breast cancer (BC) is the second leading cause of cancer death in women, although recent scientific and technological achievements have led to significant improvements in progression-free disease and overall survival of patients. Genetic mutations and epigenetic modifications play a critical role in...
Autores principales: | Varghese, Benluvankar, Del Gaudio, Nunzio, Cobellis, Gilda, Altucci, Lucia, Nebbioso, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581295/ https://www.ncbi.nlm.nih.gov/pubmed/34778065 http://dx.doi.org/10.3389/fonc.2021.750315 |
Ejemplares similares
-
The KDM Inhibitor GSKJ4 Triggers CREB Downregulation via a Protein Kinase A and Proteasome-Dependent Mechanism in Human Acute Myeloid Leukemia Cells
por: Illiano, Michela, et al.
Publicado: (2020) -
SIRT1 activation promotes energy homeostasis and reprograms liver cancer metabolism
por: Varghese, Benluvankar, et al.
Publicado: (2023) -
The Pan-Sirtuin Inhibitor MC2494 Regulates Mitochondrial Function in a Leukemia Cell Line
por: Carafa, Vincenzo, et al.
Publicado: (2020) -
Autophagy Function and Dysfunction: Potential Drugs as Anti-Cancer Therapy
por: Cuomo, Francesca, et al.
Publicado: (2019) -
The Ubiquitin Proteasome System in Hematological Malignancies: New Insight into Its Functional Role and Therapeutic Options
por: Di Costanzo, Antonella, et al.
Publicado: (2020)